The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.


Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
U.S. Government Faces Brief Shutdown as Congress Delays Funding Deal
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
India Budget 2026: Modi Government Eyes Reforms Amid Global Uncertainty and Fiscal Pressures
Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



